Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
RNA, U6 small nuclear 168, pseudogene (RNU6-168P) is classified as a pseudogene of a small nuclear RNA (snRNA) gene; it is located on chromosome 5q34 (163796065-163796165, GRCh38)[2][7]. It has no known function, protein product, or direct biological activity because it is a pseudogene, meaning it is a non-functional genomic DNA sequence derived from a functional gene (in this case, the U6 snRNA, which is involved in mRNA splicing as a critical RNA component of the spliceosome)[5][3]. There is no evidence that RNU6-168P encodes a functional transcript, participates in cellular pathways, is a therapeutic target, or has associated disease relevance. It is not used as a biomarker, is not known to interact with any drugs, and does not present safety concerns because it lacks expression and function[5][2][3].
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on RNA, U6 small nuclear 168, pseudogene (RNU6-168P).